Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

CoAxia gets $21.5mm through its Series D round

Executive Summary

First-time backer Sofinnova Partners has led CoAxia's (ischemia devices) $21.5mm oversubscribed Series D venture round and will contribute a board member. All prior major investors--Affinity Capital Management, Baird Venture Partners, Canaan Venture Partners, Johnson & Johnson Development Corp., and Prism Ventureworks--participated. CoAxia will use the funds to finish its pivotal trial of NeuroFlo for acute ischemic stroke and to investigate the product in combination with other devices and drugs.

Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies